Investigation of The Relationship Between Congenital Hypothyroidism and Respiratory Distress Syndrome in Very Low Birth Weight Newborns

Abstract

Objectives: Respiratory distress syndrome (RDS) is associated with severe morbidity and mortality, which occurs due to surfactant deficiency in the lung. In the present study, we aimed to determine the risk factors for RDS and the effect of congenital hypothyroidism (CH) on RDS in very low birth weight (VLBW<1500 g) infants. Materials and Methods: The study was completed between January 2013 and August 2017. Data of eligible infants were obtained from hospital medical records. Patients were divided in to groups with and without CH, and those with and without RDS according to requirement of surfactant therapy. Results: Six hundred and seventy patients of 729 patients (gestational age: 27.5±1.3 weeks, birth weight: 1014±219 g) were included in the study, and thyroid function test results were obtained on day 5th respiratory distress syndrome ratio was 71.4% (n=20) in the CH group (n=28) and 61.3% (n=394) in the non-CH group (n=642). Respiratory distress syndrome ratio (71.4%) was found to be statistically higher in CH group than those in non-CH group (61.3%) (p=0.000). The frequency of CH (5.3% vs 2.3%, p=0.015, respectively) was higher in patients with RDS. RDS ratio in those with CH and CHD in those with RDS were found to be higher. Conclusion: Based on these findings, it is thought that thyroid hormones may affect lung development and dynamics.

Keywords

• Very Low Birth Weight
• Congenital Hypothyroidism
• Prematurity
• Respiratory Distress Syndrome

Ethical Statement

Çalışma için Zekai Tahir Burak Eğitim ve Araştırma Hastanesi Yerel Etik Kurulu’ndan onam alınmıştır (karar no: 160/2017, tarih: 19.12.2017).

Çok Düşük Doğum Ağırlıklı Yenidoğanlarda Konjenital Hipotiroidi ve Respiratuvar Distres Sendromu İlişkisinin Araştırılması

Abstract

References

1. 1. Dilmen U, Özdemir R, Tatar Aksoy H, et al. Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study. J Matern Fetal Neonatal Med. 2014;27:411-415.
2. 2. Sweet DG, Carnielli V, Greisen G, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update. Neonatology. 2017;111:107-125.
3. 3. Wiingreen R, Greisen G, Ebbesen F, et al. Surfactant Need by Gestation for Very Preterm Babies Initiated on Early Nasal CPAP: A Danish Observational Multicentre Study of 6,628 Infants Born 2000-2013. Neonatology. 2017;111:331-336.
4. 4. Dizdar EA, Sari FN, Aydemir C, et al. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome. Am J Perinatol. 2012;29:95-100.
5. 5. Sardesai S, Biniwale M, Wertheimer F, et al. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future. Pediatr Res. 2017;81:240-248.
6. 6. Tanaka K, Shimizu T, Hosaka A, et al. Serum free T4 and thyroid stimulating hormone levels in preterm infants and relationship between these levels and respiratory distress syndrome. Pediatr Int. 2007;49:447-451.
7. 7. Atasay B, Ergun H, Okulu E, et al. The association between cord hormones and transient tachypnea of newborn in late preterm and term neonates who were delivered by cesarean section. J Matern Fetal Neonatal Med. 2013;26:877-880.
8. 8. Behme RM, Mackley AB, Bartoshesky L, et al. Thyroid function in late preterm infants in relation to mode of delivery and respiratory support. J Pediatr Endocrinol Metab. 2014;27:425-430.

9. 9. Heidari Z, Feizi A, Hashemipour M, et al. Growth development in children with congenital hypothyroidism: the effect of screening and treatment variables-a comprehensive longitudinal study. Endocrine. 2016;54:448- 459
10. 10. Baysal BT, Baysal B, Genel F, et al. Neurodevelopmental Outcome of Children with Congenital Hypothyroidism Diagnosed in a National Screening Program in Turkey. Indian Pediatr. 2017;54:381-384.
11. 11. Paul DA, Leef KH, Voss B, et al. Thyroxine and illness severity in very lowbirth- weight infants. Thyroid. 2001;11:871-875.
12. 12. Chiesa A, Prieto L, Mendez V, et al. Prevalence and etiology of congenital hypothyroidism detected through an argentine neonatal screening program (1997-2010). Horm Res Paediatr. 2013;80:185-192.
13. 13. Olivieri A1, Fazzini C, Medda E; Italian Study Group for Congenital Hypothyroidism. Multiple factors influencing the incidence of congenital hypothyroidism detected by neonatal screening. Horm Res Paediatr. 2015;83:86-93.
14. 14. Fenton TR. A new growth chart for preterm babies: Babson and Benda’s chart updated with recent data and new format. BMC Pediatr. 2003;16:3- 13.
15. 15. Dargaville PA, Gerber A, Johansson S, et al. Australian and New Zealand Neonatal Network. Incidence and Outcome of CPAP Failure in Preterm Infants. Pediatrics. 2016; 138. pii: e20153985.
16. 16. Bizzarro MJ, Gross I. Effects of hormones on fetal lung development. Obstet Gynecol Clin North Am. 2004;31:949-961, xii.
17. 17. Ryckman KK, Spracklen CN, Dagle JM, et al. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone. J Pediatr Endocrinol Metab. 2014;27:929-938.
18. 18. Paul DA, Mackley A, Yencha EM. Thyroid function in term and late preterm infants with respiratory distress in relation to severity of illness. Thyroid. 2010;20:189-194.
19. 19. Respiratuvar Distres Sendromu ve Surfaktan Tedavı Rehberi. Türk Neonatoloji Derneği 2018 Güncellemesi.
20. 20. Hashemipour M, Hovsepian S, Ansari A, et al. Screening of congenital hypothyroidism in preterm, low birth weight and very low birth weight neonates: A systematic review. Pediatr Neonatol. 2017;9572:30452-30457 pii: S1875.
21. 21. Lee JH, Kim SW, Jeon GW, et al. Thyroid dysfunction in very low birth weight preterm infants. Korean J Pediatr. 2015;58:224-229.
22. 22. Osborn DA, Hunt RW. Postnatal thyroid hormones for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2007:CD005946.